Jon Coe
2.8K posts

Jon Coe
@coezycoe
mid-wit-certified by wife, Little League Coach, MIT baseball turned Giants/Cardinal homer, inventor 10^2+, CEO @ https://t.co/5Nyr8kezJX

I hired a local pro to handle the mounting. He quoted $250, I gave him $300. He showed up fast, brought a second guy, and did a flawless job. A lot of people in the replies completely missed the point. This was never about the physical act of hanging a TV on a wall. It was about paying for a service that a massive retailer simply refused to fulfill. @BestBuy took the money and walked away from the job. They will never see another dime from me.



Sound the alarm. The VCs are now publishing essays about the value of Brand. The “taste” bros will follow suit.


U.S. payrolls unexpectedly fell by 92,000 in February; unemployment rate rises to 4.4% cnbc.com/2026/03/06/feb…







I’m a baseball player. I’ve never written a single line of code in my life. But over the last few months, I used AI to build a pitching analytics platform from scratch. 8.9M pitches. Custom ML models. Total transparency. Here is a look at what happens when you give an interested athlete access to AI:


working in an innovative environment means that you can never lean back and stay calm for one or two years. It's always moving forward. Change is everywhere. Re-dos of trainings, new things rise up quarterly and when you just think, you made it, the software update forces you to go back to the start and re-learn everything. Don't underestimate this, when you invest money in a solution "that makes the surgeon’s life easier"!



Elon Musk just put an expiration date on the medical profession. And he gave it three years. The interviewer asked when Optimus would be a better surgeon than the best surgeons on Earth. Musk didn’t hesitate. Musk: “Three years. I’d say three years at scale.” Not a prototype. Not a lab experiment. At scale. To understand why that timeline is plausible, you have to understand the fundamental problem with human medicine. Musk: “Takes a super long time to learn to be a good doctor. And even then, the knowledge is constantly evolving. It’s hard to keep up with everything.” Musk: “Doctors have limited time. They make mistakes. How many great surgeons are there? Not that many.” That is the brutal reality of the greatest healthcare system humanity has ever built. It runs on exhausted humans with biological limits, trained over decades, who can only operate on one patient at a time. Optimus has none of those constraints. It doesn’t get tired. It doesn’t forget a study published last week. It doesn’t have an off day. It doesn’t have a caseload limit. And once you train one, you can manufacture ten thousand more with identical precision. Musk: “At that point, there will probably be more Optimus robots that are great surgeons than there are on Earth.” Think about what that actually means. The scarcity of elite surgical skill has been one of the defining limits of human healthcare since the beginning of medicine. Geography determined your odds of survival. Zip code determined your access to expertise. That bottleneck disappears overnight. Because you can’t train human surgeons fast enough to meet global demand. But you can manufacture infinite robots running identical perfect code. The most valuable skill in the world is about to become software. Infinitely replicable. Infinitely scalable. Available to every human being on Earth regardless of where they were born. Medical scarcity doesn’t fade gradually under that reality. It ends. And whoever controls that code controls healthcare access for billions. For all of human history, the leading cause of preventable death wasn’t disease. It was the shortage of great people to fight it. That problem has a solution now. And it ships in three years.









Everything about cancer sucks. Some of the most difficult decisions in cancer are what to do and when to do it: biopsy, resection, passive monitoring etc. Today, clinicians make irreversible calls like 1) do a biopsy or wait, 2) treat or monitor or 3) remove an organ or monitor, using tests that cannot see the full biology of either the body or the cancer. As a result, doctors often overtreat the wrong patients while missing dangerous cancers in others until it’s too late. Five years ago, a sibling trio of Purdue grads cold emailed me from Indianapolis. Their thesis was simple: the science in cancer detection and treatment isn't the bottleneck. The engineering is. Fix the engineering, and you can change the standard of care of cancer forever. We founded @EarlyIsGood together to do this. Here is our mid-decade update after five years (!) of toil. We’ve made some good progress. 1. The Engineering Unlock: Multiomics Most diagnostics fail because they are looking for a needle in a haystack. The results are modest and create many false positives and false negatives. We developed nanotechnology that amplifies the needle making it simpler for us to figure out what is going on. Our nanotechnology allows us to read DNA, RNA, and Proteins simultaneously from a single sample. We detect Proteins at attomolar sensitivity (1000x ELISA) and RNAs at PCR-level sensitivity all without extraction or amplification. Combining all three provides a full picture because: - DNA tells you what mutations are present - RNA tells you what the cancer is doing - Proteins tell you how the body is responding 2. The Proof: Bladder Cancer We started here because the standard of care today is barbaric. 800,000 people are under surveillance for bladder cancer, enduring invasive cystoscopies that still miss ~20% of tumors. We are finishing a multisite prospective trial now. Standard of Care (Cystoscopy): invasive, repeated every 3-6 months. Our bladder cancer test (BCDx): 92% sensitivity and 97% specificity from a simple urine sample. Most importantly, we catch the high-grade tumors that the current gold standard misses completely. 3. The Next Mountain to Climb: Prostate Cancer If you’ve watched a father, brother, or friend get a high PSA result, you know the spiral that follows: months of terror, invasive procedures, and paralyzing uncertainty. 20M+ PSA tests are run annually. Most positives are false alarms, leading to 1M+ unnecessary, painful biopsies. Meanwhile, dangerous cancers are often missed. Current commercial tests hover below 50% specificity. That means for every two men they flag, one is a false alarm. We partnered with the Mayo Clinic to solve this. No blood draws. No rectal exams. Just a simple urine test. We are using the same platform that we validated on bladder cancer to achieve unprecedented specificity without sacrificing sensitivity, effectively separating those who need treatment from those who don't. We will soon be commercializing both our bladder and prostate cancer tests widely. Follow us @EarlyIsGood if you’d like to help or know when/where these tests are available.



@stoolpresidente I love that idea , what a genius
